Avaamo has raised $20.0M in total across 2 funding rounds.
Avaamo's investors include Intel Capital, Rembrandt Venture Partners.
Avaamo is a deep-learning software company specializing in conversational AI and agentic AI platforms for enterprises, enabling autonomous agents that handle employee support, workforce management, customer service, and healthcare documentation.[1][2][3][5] It builds products like the Avaamo LLaMB framework, Agent Assist Copilot, AutoQA for contact centers, and ambient listening tools, serving global enterprises in sectors such as banking, insurance, telco, retail, manufacturing, healthcare, HR, and IT service desks by automating complex workflows across 114+ languages and 200+ integrations.[3][4][5] These solutions solve high-impact problems like reducing agent handling time, combating physician burnout, achieving 100% call coverage with low-latency transcription, and delivering real-time insights, with strong growth shown through innovations like GenAI-powered tools and over 2 billion annual interactions.[1][3][4]
Avaamo was founded by enterprise veterans from TIBCO, SAP, Siebel, and Apple, bringing deep expertise in software and AI to pioneer conversational computing for enterprises.[2] The idea emerged from developing fundamental AI technologies in neural networks, speech synthesis, and deep learning to address enterprise-specific challenges in conversational interfaces, starting with a patented multi-engine NLU for complex queries across industries.[1][2] Early traction included innovations like omni-channel infrastructure for CX automation, 150+ integrations, and partnerships such as with Intel for optimized architectures, evolving into a full agentic AI platform with pre-built vertical models for rapid deployment.[1][4]
Avaamo rides the agentic AI trend, shifting from hype-driven chatbots to production-ready autonomous agents that integrate with enterprise systems for real business value in contact centers, employee support, and healthcare.[5] Timing aligns with GenAI maturity, where low-latency, secure tools address deployment failures in regulated sectors amid rising demands for 24/7 personalization and efficiency.[1][3][5] Market forces like physician burnout, CX automation needs, and multi-channel interactions favor its omni-channel, multilingual capabilities, influencing the ecosystem by setting standards for holistic agent assistance and enabling partners like Genesys to scale inbound/outbound automation.[1][4]
Avaamo is positioned to expand its agentic AI dominance with deeper GenAI integrations, targeting healthcare agents that adapt to patient journeys and copilot expansions for global contact centers.[1][3][5] Trends like AI trust layers for compliance and real-time analytics from conversations will propel growth, evolving its influence from automation pioneer to essential infrastructure for enterprise AI workforces. This builds on its foundational innovations, turning conversational AI into scalable, human-like intelligence that drives efficiency across industries.[2][5]
Avaamo has raised $20.0M across 2 funding rounds. Most recently, it raised $14.0M Series A in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2018 | $14.0M Series A | Intel Capital | |
| Oct 1, 2014 | $6.0M Seed | Rembrandt Venture Partners |
